Senior insider sale
Chief People Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$2.02M
133.32K shares
What this filing means
LO FRANCIS plans to sell 133.32K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $2.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001950047-26-005640
Officer· Chief People Officer
Since Jun 2019
133.32K
Shares to sell
$2.02M
Approx. market value
42.09K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
6/4/2026
21.86KRestricted Stock Units
N/A
3/4/2025
20.22KTotal acquired42.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2026 | Exercise of Stock Options Cash | 21.86K | — |
3/4/2025 | Restricted Stock Units N/A | 20.22K | — |
| Total | 42.09K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
22.56K
Market value
$339.9K
4/8/2026
—Completed
Units to sell
30.59K
Market value
$430.6K
3/11/2026
—Completed
Units to sell
38.07K
Market value
$574.5K
3/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
42.09K
Market value
$672.9K
6/4/2026
Total
Units
133.32K
Value
$2.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/8/2026 | 22.56K | $339.9K | — | Completed |
3/11/2026 | 30.59K | $430.6K | — | Completed |
3/5/2026 | 38.07K | $574.5K | — | Completed |
| Planned — Approximate Date | ||||
6/4/2026 | 42.09K | $672.9K | NASDAQ | Planned |
| Total | 133.32K | $2.02M | ||